Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 26, 2021

SELL
$4.17 - $5.74 $143,860 - $198,024
-34,499 Closed
0 $0
Q1 2021

Apr 28, 2021

SELL
$5.28 - $9.64 $5,749 - $10,497
-1,089 Reduced 3.06%
34,499 $182,000
Q4 2020

Jan 28, 2021

BUY
$5.75 - $7.13 $3,691 - $4,577
642 Added 1.84%
35,588 $232,000
Q3 2020

Oct 30, 2020

BUY
$4.9 - $7.12 $328 - $477
67 Added 0.19%
34,946 $213,000
Q2 2020

Jul 31, 2020

BUY
$6.43 - $9.86 $15,567 - $23,871
2,421 Added 7.46%
34,879 $253,000
Q1 2020

May 01, 2020

BUY
$6.36 - $10.05 $7,733 - $12,220
1,216 Added 3.89%
32,458 $225,000
Q4 2019

Feb 07, 2020

SELL
$8.49 - $12.81 $636 - $960
-75 Reduced 0.24%
31,242 $275,000
Q3 2019

Oct 31, 2019

BUY
$5.58 - $14.47 $133 - $347
24 Added 0.08%
31,317 $350,000
Q2 2019

Aug 02, 2019

SELL
$5.22 - $9.08 $14,146 - $24,606
-2,710 Reduced 7.97%
31,293 $0
Q1 2019

May 02, 2019

BUY
$5.35 - $9.82 $9,383 - $17,224
1,754 Added 5.44%
34,003 $0
Q4 2018

Feb 06, 2019

BUY
$3.43 - $6.19 $874 - $1,578
255 Added 0.8%
32,249 $242,000
Q3 2018

Nov 01, 2018

SELL
$4.75 - $14.5 $261 - $797
-55 Reduced 0.17%
31,994 $118,000
Q2 2018

Aug 01, 2018

BUY
$13.3 - $17.45 $5,599 - $7,346
421 Added 1.33%
32,049 $421,000
Q1 2018

May 01, 2018

BUY
$14.7 - $24.95 $5,953 - $10,104
405 Added 1.3%
31,628 $527,000
Q4 2017

Feb 02, 2018

SELL
$19.9 - $29.25 $9,293 - $13,659
-467 Reduced 1.47%
31,223 $717,000
Q3 2017

Nov 06, 2017

BUY
$15.1 - $19.25 $478,519 - $610,032
31,690
31,690 $730,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.